Cruz ARE, Gutiérrez HAE, Brito VD, Chávez GE

Language: Spanish
References: 25
Page: 429-435
PDF size: 307.52 Kb.

ABSTRACT

Introduction: P wave duration and dispersion are noninvasive markers for the prediction of atrial fibrillation risk in patients treated with hemodialysis.
Objective: To determine P wave variations and dispersion in patients with stage 5 chronic kidney disease treated with periodic hemodialysis.
Method: A longitudinal, observational, prospective study was carried out from October 2016 to April 2018.
Results: Seventy-one patients (47 males) were included, averaging 56 years of age; P wave duration at the beginning of hemodialysis was 75.91 milliseconds and at the end was 81.2; p<0.001. Maximum P wave increased from 95.25 to 101.16 milli-seconds; p<0.001. P wave dispersion did not show significant changes. In patients with more than one-year arteriovenous fistula, P wave dispersion increased from 35 milliseconds to 43.6 at the end of hemodialysis, with no significant differences. Increases in maximum P wave duration were significant regardless of smaller or larger left atrial size. P wave dispersion did not show significant differences when compared with left atrial size. Thrombolysis percentage in Group II was higher than 50% in most of the centers.
Conclusions: P wave dispersion did not show significant changes during hemodi-alysis as has been observed in different international studies. Average/maximum P wave duration show significant increases that are probably the expression of changes in the heterogeneity of atrial conduction in the sample studied.

REFERENCES

1. Bello AK, Levin A, Tonelli M, Okpechi IG, Fee-hally J, Harris D, et al. Global Kidney Health At-las: A report by the International Society of Neph-rology on the current state of organization and structures for kidney care across the globe [In-ternet]. Brussels: International Society of Neph-rology [citado 3 Sep 2020]; 2017. Disponible en: http://www. nephro. ru/content/files/news/GKHAtlas_ISN_17. pdf

2. González-Bedat MC, Rosa-Diez G, Fernández-Cean JM, Ordúñez P, Ferreiro A, Douthat W. Los regis-tros nacionales de diálisis y trasplante renal en América Latina: cómo implementarlos y mejorar-los. Rev Panam Salud Publica. 2015;38(3):254-60.

3. Bencomo Rodríguez O. Enfermedad Renal Cróni-ca: prevenirla, mejor que tratarla. Rev Cuban Med Gen Integr [Internet]. 2015 [citado 3 Sep 2020];31(3). Disponible en:http://www. revmgi. sld. cu/index. php/mgi/article/view/66/24

4. Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, et al. Documento de la Sociedad Española de Nefrolo-gía sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica. Nefrologia. 2014;34(3):273-424. [DOI]

5. Herrera Valdés R. Enfermedad renal crónica: enfoque sistémico epidemiológico-clínico e inter-sectorial. En: Alfonso Guerra JP. Nefrología. La Habana: Editorial Ciencias Médicas; 2016. p. 102-29.

6. Cuba. Centro Nacional de Información de Cien-cias Médicas. Biblioteca Médica Nacional. Enfer-medad Renal Crónica. Factores de Riesgo. Biblio-med [Internet]. 2017 [citado 4 Sep 2020];24(4). Disponible en:http://files. sld. cu/bmn/files/2017/04/bibliomed-abril-2017. pdf

7. Escamilla-Cejudo JA, Lara Báez J, Peña R, Ruiz Luna PL, Ordunez P. Optimización del registro de muerte por enfermedad renal crónica en las co-munidades agrícolas de América Central. Rev Panam Salud Publica. 2016;40(5):285-93.

8. Saran R, Robinson B, Abbott KC, Agodoa LY, Al-bertus P, Ayanian J, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kid-ney Disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7-A8. [DOI]

9. Weiner DE, Nicholls AJ, Sarnak MJ. Enfermedad Cardiovascular. En: Daugirdas JT, Blake PG, Todd S. Manual de Diálisis. 4a Ed. Filadelfia: Lippincott Williams & Wilkins; 2007. p. 453-66.

10. Aquiles Jara C. Calcificaciones vasculares en pa-cientes con insuficiencia renal crónica. Rev Med Clin Condes. 2012;23(6):715-23. [DOI]

11. Guerra Bustillo GJ. Complicaciones cardiacas. En: Magrans Buch Ch, Barranco Hernández E, Ibars Bolaños EV. Hemodiálisis y Enfermedad Renal Crónica. La Habana: Editorial Ciencias Médicas; 2016. p. 319-50.

12. Faulkner A, Garrett A. Effect of gender on P-wave dispersion in asymptomatic populations. Int SportMed J [Internet]. 2013 [citado 5 Sep 2020]; 14(4):236-44. Disponible en:https://hdl. handle. net/10520/EJC146797

13. Marchlinski F. Taquiarritmias. En: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison Principios de Medicina In-terna. 18ª Ed. Nueva York: McGraw-Hill; 2012. p. 1881-2.

14. Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis [Internet]. 2016 [citado 6 Sep 2020];5: 2048004016639443. Disponible en:https://doi. org/10. 1177/2048004016639443

15. Acampa M, Lazzerini PE, Martini G. How to identi-fy patients at risk of silent atrial fibrillation aftercryptogenic stroke: Potential role of P wave dis-persion. J Stroke. 2017;19(2):239-41. [DOI]

16. Drighil A, Madias JE, El Mosalami H, El Badaoui N, Mouine B, Fadili W, et al. Impact of hemodialy-sis on P-wave amplitude, duration, and disper-sion. Indian Pacing Electrophysiol J. 2007;7(2):85-96.

17. Szabó Z, Kakuk G, Fülöp T, Mátyus J, Balla J, Kárpáti I, et al. Effects of haemodialysis on maxi-mum P wave duration and P wave dispersion. Nephrol Dial Transplant. 2002;17(9):1634-8. [DOI]

18. Páll A, Czifra Á, Sebestyén V, Becs G, Kun C, Balla J, et al. Hemodiafiltration and hemodialysis dif-ferently affect P wave duration and dispersion on the surface electrocardiogram. Int Urol Nephrol. 2016;48(2):271-7. [DOI]

19. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Sim-ple electrocardiographic markers for the predic-tion of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135(5 Pt 1):733-8. [DOI]

20. Pérez-Riera AR, de Abreu LC, Barbosa-Barros R, Grindler J, Fernandes-Cardoso A, Baranchuk A. P-wave dispersion: an update. Indian Pacing Elec-trophysiol J. 2016;16(4):126-33.

21. Censi F, Corazza I, Reggiani E, Calcagnini G, Mattei E, Triventi M, et al. P-wave Variability and Atrial Fibrillation. Sci Rep [Internet]. 2016 [citado 10 Sep 2020];6:26799. Disponible en:https://doi. org/10. 1038/srep26799

22. Chen SC, Su HM, Huang JC, Chang K, Tsai YC, Chen LI, et al. Association of P-Wave Dispersion with Overall and Cardiovascular Mortality in He-modialysis Patients. Am J Nephrol. 2015;42(3):198-205. [DOI]

23. Kollu K, Altintepe L, Duran C, Topal M, Ecirli S. The assessment of P-wave dispersion and myo-cardial repolarization parameters in patients with chronic kidney disease. Ren Fail. 2018;40(1):1-7. [DOI]

24. Akin F, Firatli I, Katkat F, Gurmen T, Ayca B, Kaly-oncuoglu M, et al. P-wave dispersion and its rela-tionship with the severity of the disease in pa-tients with stable coronary artery disease. North Clin Istanb [Internet]. 2014 [citado 10 Sep 2020]; 1(2):65-70. Disponible en:https://doi. org/10. 14744/nci. 2014. 25733

25. Giese A, Ornek A, Kurucay M, Kara K, Wittkowski H, Gohar F, et al. P wave dispersion and QT dis-persion in adult Turkish migrants with familial mediterranean fever living in Germany. Int J Med Sci. 2014;11(11):1140-6. [DOI]